Cargando…
Volumetric parameters from [ (18)F]FDG PET/CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms
A positive fluorine‐18 labelled 2‐deoxy‐2‐fluoroglucose ([(18)F]FDG) positron emission tomography/computed tomography (PET/CT) has been associated with more aggressive disease and less differentiated neuroendocrine neoplasms (NEN). Although a high maximum standardized uptake value (SUV(max)) predict...
Autores principales: | Langen Stokmo, Henning, Aly, Mahmoud, Bowitz Lothe, Inger Marie, Borja, Austin J., Mehdizadeh Seraj, Siavash, Ghorpade, Rina, Miao, Xuan, Hjortland, Geir Olav, Malinen, Eirik, Sorbye, Halfdan, Werner, Thomas J., Alavi, Abass, Revheim, Mona‐Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539477/ https://www.ncbi.nlm.nih.gov/pubmed/35729738 http://dx.doi.org/10.1111/jne.13170 |
Ejemplares similares
-
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021) -
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
por: Knappskog, Stian, et al.
Publicado: (2023) -
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020) -
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
por: Ali, Abir Salwa, et al.
Publicado: (2017) -
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
por: Ali, Abir Salwa, et al.
Publicado: (2018)